IL6 and cancer: Mφ can activate the NF‐κB signaling pathway by secreting factors such as S100A9 and IL-6, which promotes the stemness of HCC cells and the self-renewal of cancer stem cells (CSCs), thus providing a pro‐tumorigenic niche for early HCC.